JAGX vs. NDRA
JAGX (Jaguar Health, Inc.) and NDRA (ENDRA Life Sciences Inc.) are both stocks. Both are in the Healthcare sector — JAGX in Biotechnology, NDRA in Diagnostics & Research. Over the past 5 years, JAGX returned -96.26%/yr vs -67.32%/yr for NDRA. Their 0.14 correlation means their historical movements had little consistent relationship.
Performance
JAGX vs. NDRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JAGX achieves a -96.29% return, which is significantly lower than NDRA's 3.75% return.
JAGX
- 1D
- -3.85%
- 1M
- -64.41%
- 6M
- -94.88%
- YTD
- -96.29%
- 1Y
- -98.25%
- 3Y*
- -96.69%
- 5Y*
- -96.26%
- 10Y*
- -90.51%
- ALL TIME*
- -89.23%
NDRA
- 1D
- 8.55%
- 1M
- -0.42%
- 6M
- 23.68%
- YTD
- 3.75%
- 1Y
- -2.89%
- 3Y*
- -52.21%
- 5Y*
- -67.32%
- 10Y*
- —
- ALL TIME*
- -50.49%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $99.03K | $113.43K | $255.58K | |
| $71.88K | $152.15K | $156.09K |
JAGX vs. NDRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JAGX Jaguar Health, Inc. | -96.29% | -96.31% | -88.88% | -97.68% | -91.64% | -57.46% | 1.75% | -95.00% | -89.10% | -74.55% |
NDRA ENDRA Life Sciences Inc. | 3.75% | -27.64% | -91.56% | -47.91% | -70.58% | -7.76% | -55.36% | 12.00% | -69.14% | 21.96% |
Correlation
The correlation between JAGX and NDRA is 0.17, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.17 |
Correlation (3Y) Balances recent behavior with more history. | 0.07 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.13 |
Correlation (All Time) Calculated using the full available price history since Jun 30, 2017 | 0.14 |
Fundamentals
JAGX:
$66.64K
NDRA:
$3.54M
JAGX:
-$27.86
NDRA:
-$9.08
JAGX:
$11.51M
NDRA:
$0.00
JAGX:
$7.74M
NDRA:
-$117.76K
JAGX:
-$45.91M
NDRA:
-$3.74M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JAGX vs. NDRA — Risk / Return Rank
JAGX
NDRA
JAGX vs. NDRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Jaguar Health, Inc. (JAGX) and ENDRA Life Sciences Inc. (NDRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JAGX | NDRA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.51 | ||
| Sortino ratioReturn per unit of downside risk | -3.08 | ||
| Omega ratioGain probability vs. loss probability | 0.69 | 1.08 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | -1.00 | -0.18 | -0.81 |
| Martin ratioReturn relative to average drawdown | -1.43 | -0.30 | -1.13 |
Loading charts...
Drawdowns
JAGX vs. NDRA - Drawdown Comparison
The maximum JAGX drawdown since its inception was -100.00%, roughly equal to the maximum NDRA drawdown of -99.97%. Use the drawdown chart below to compare losses from any high point for JAGX and NDRA.
Loading charts...
Drawdown Indicators
| JAGX | NDRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -99.97% | -0.03% |
Max Drawdown (1Y)Largest decline over 1 year | -98.71% | -59.85% | -38.86% |
Max Drawdown (3Y)Largest decline over 3 years | -100.00% | -98.70% | -1.30% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -99.92% | -0.08% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -99.88% | -0.12% |
Average DrawdownAverage peak-to-trough decline | -94.13% | -79.55% | -14.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 68.63% | 37.22% | +31.41% |
Volatility
JAGX vs. NDRA - Volatility Comparison
Jaguar Health, Inc. (JAGX) has a higher volatility of 46.04% compared to ENDRA Life Sciences Inc. (NDRA) at 26.47%. This indicates that JAGX's price experiences larger fluctuations and is considered to be riskier than NDRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JAGX | NDRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 46.04% | 26.47% | +19.57% |
Volatility (6M)Calculated over the trailing 6-month period | 119.10% | 78.02% | +41.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 159.20% | 107.24% | +51.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 138.80% | 874.28% | -735.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 172.18% | 652.07% | -479.89% |
Dividends
JAGX vs. NDRA - Dividend Comparison
Neither JAGX nor NDRA has paid dividends to shareholders.
Financials
JAGX vs. NDRA - Financials Comparison
This section allows you to compare key financial metrics between Jaguar Health, Inc. and ENDRA Life Sciences Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
JAGX and NDRA have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JAGX has higher volatility (46.04%) compared to NDRA (26.47%). In terms of maximum drawdown, JAGX dropped -100.00% vs NDRA's -99.97%.
NDRA currently has the higher Sharpe Ratio (-0.10 vs -0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JAGX and NDRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer